Sexually Transmitted Infections Treatment Guidelines, 2021
Open accessThe DOI matches its Crossref record; 1,459 of the 1,505 references it cites were found in a registry or an index; 371 of the 802 sources its claims cite were checked for support.
Abstract
These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.
Overview
CoChat Summary
TL;DR
These CDC guidelines update the 2015 STI treatment recommendations after expert consultation and systematic literature review, covering prevention, diagnosis, treatment, and special populations. They include updated guidance for gonorrhea, chlamydia, trichomoniasis, pelvic inflammatory disease, bacterial vaginosis, *Mycoplasma genitalium*, HPV vaccination, syphilis screening in pregnancy, hepatitis C testing, sexual assault evaluation, and HSV serology.
Key findings
- Congenital syphilis in the United States increased from 8.4 to 48.5 cases per 100,000 births during 2012–2019, a 477.4% increase.
- Three randomized controlled trials in sub-Saharan Africa found male circumcision reduced HIV acquisition among men by 50%–60%; HPTN 052 found ART for the infected partner decreased HIV transmission to uninfected heterosexual partners by 96%.
- Doxycycline postexposure prophylaxis after unprotected anal sex among MSM and transgender women reduced incident chlamydia and syphilis by 70% and 73%, respectively, but had no effect on gonorrhea.
- Expedited partner therapy trials showed reductions in chlamydia prevalence at follow-up of approximately 20% and gonorrhea of approximately 50%.
Methods
- CDC staff worked with subject matter experts to identify key questions and conduct systematic MEDLINE-based literature reviews for each section of the 2015 guidelines, focused on microbiologic eradication, symptom alleviation, prevention of sequelae, and prevention of transmission.
- Experts presented literature assessments at an in-person meeting in Atlanta, Georgia, June 11–14, 2019; evidence was rated high, medium, or low using USPSTF-style ratings, and draft recommendations underwent peer review and a public webinar before finalization.
- Recommendations for HIV, hepatitis C, cervical cancer screening, STI screening in pregnancy, HPV testing, and HAV/HBV vaccination were developed after reviewing existing published recommendations.
Limitations
- The paper states these guidelines are “a source of clinical guidance rather than prescriptive standards” and that providers should consider each person’s clinical circumstances and local disease prevalence.
- The paper states several evidence gaps, including limited data on doxycycline STI prophylaxis, no long-term data on STI postexposure prophylaxis effects on antimicrobial resistance and the microbiome, and insufficient data to recommend routine anal cancer screening with anal cytology.
- Evident from the text: many recommendations, especially for syphilis treatment, rely on decades of clinical experience and observational data rather than randomized controlled trials; the document is a broad guideline rather than a single primary study with a defined sample or comparator.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
221 Valid · 41 Not valid · 158 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Clinical Prevention Guidance > Primary Prevention Methods
What the sources say
- Disputedcites [47] Abdool Karim Q, Abdool Karim SS, Frohlich JA,; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168– 74. Erratum in: Science 2011;333:524. 10.1126/science.1193748 20643915 PMC3001187 sourceExperimental — accuracy not yet measured
The Results (‘HIV incidence and effectiveness’; page unavailable) report 5.6 HIV infections per 100 women-years with tenofovir gel versus 9.1 with placebo (p=0.017) in a trial of women. The Discussion states that the gel reduced HIV infection by an estimated 39%. Although the authors call for corroboration, their findings directly contradict the claim that prevention had not been demonstrated. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [49] Delany-Moretlwe S, Lombard C, Baron D, Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2018; 18: 1241– 50. 10.1016/S1473-3099(18)30428-6 30507409 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, nontreponemal test titers might decrease more slowly for persons previously treated for syphilis (594,595).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Could not verifycites [594] Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83: 97– 101. 10.1136/sti.2006.021402 16943224 PMC2598600 sourceExperimental — accuracy not yet measured
The Results (page unavailable) mention a history of syphilis infection, but do not compare titre declines by prior treatment history. The paper compares response times by HIV status and syphilis stage; searches for prior treatment and serological response found no passage addressing whether previously treated patients’ titres decline more slowly. (LLM, conf=0.76)
- Disputedcites [595] Seña AC, Wolff M, Martin DH, Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 2011; 53: 1092– 9. 10.1093/cid/cir671 21998287 PMC3205200 sourceExperimental — accuracy not yet measured
In Characteristics Associated With Serological Cure (page unavailable), the paper reports that a history of syphilis was not significantly associated with serological cure; the Discussion likewise says it found no association between history of syphilis and serological response. It mentions a prior study finding less seroreversion after repeat infection, but that is not a finding that titers decrease more slowly in previously treated persons. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that use of additional doses of benzathine penicillin G, amoxicillin, or other antibiotics do not enhance efficacy of this recommended regimen when used to treat primary and secondary syphilis, regardless of HIV status (591–593).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Not checked — no full text of the sourcecites [591] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) explicitly says that, among HIV-infected patients with early syphilis, one dose of benzathine penicillin G was inferior to three weekly doses for serological response at 12 months—the opposite of the claim about additional doses. The study excluded patients who received other antibiotics, so it does not establish whether adding amoxicillin or other antibiotics helps; it also does not establish the claim regardless of HIV status. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Factors Associated With Treatment Response section reports similar responses with one versus multiple BPG doses in HIV-infected people with early syphilis. The study does not establish that adding amoxicillin or other antibiotics to the recommended regimen offers no benefit: its “other” regimens were grouped together and could be alternatives rather than additions. Nor do its findings establish the result regardless of HIV status; the Discussion also notes limited power for people with advanced immunosuppression. Page numbers were not available in our copy. (LLM, conf=0.89)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in early latent syphilis do not enhance efficacy, regardless of HIV status (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Latent Syphilis
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were associated with a higher serological response than one dose in patients with HIV and early syphilis; the Discussion explicitly calls the one-dose regimen inferior at 12 months. This contradicts the claim that additional doses do not enhance efficacy. The study did not test additional amoxicillin or other antibiotics, or patients without HIV. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results report similar treatment responses with one versus multiple BPG doses in HIV-infected people with early syphilis. However, the Data Analysis and Definitions section says syphilis stage was not consistently captured, and the study did not establish the claim specifically for early latent syphilis, amoxicillin or other added antibiotics, or people without HIV. The Discussion further limits its conclusion to patients with preserved CD4 counts and low viral loads. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in primary and secondary syphilis among persons with HIV infection do not result in enhanced efficacy (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Syphilis Among Persons with HIV Infection
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were independently associated with a higher serological response than one dose in HIV-infected patients with early syphilis. The Discussion says the subgroup results generally favored three doses, except among patients presenting with primary syphilis; the study did not test additional amoxicillin or other antibiotics. These findings contradict the cited sentence’s blanket claim of no enhanced efficacy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results (Factors Associated With Treatment Response; page not provided) found similar serologic responses with one versus multiple BPG doses in HIV-infected people with early syphilis. It also found no improved response for a pooled “other” regimen group, but the Data Analysis and Definitions section says that group combined penicillin derivatives used alone or with BPG and non-penicillin antibiotics. The paper therefore does not establish the claim specifically for additional amoxicillin or each other antibiotic. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
264 more claims · 126 with their cited sources checked
Create a free account to see all 502 claims and to verify the 10 references still open.
- Probably not a substantial claim. 72
- It may state two separate claims as one. 188
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a reduction of half the risk of perinatal death (RR, 0.50; 95% CI: 0.33-0.84) (5) as long as treatment for GS been administered 30 days before delivery 5.”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The strategy of early diagnosis with rapid tests and immediate treatment (on the same day) with at least one dose of benzathine penicillin leads to a reduction of about 98% in the incidence of CS (relative risk (RR), 0.02; 95% confidence interval (CI: 0.00-0.18)”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer that is fourfold§ (or greater) higher than the mother’s titer at delivery (e.g., maternal titer = 1:2, neonatal titer ≥1:8 or maternal titer = 1:8, neonatal titer ≥1:32)¶;”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer equal to or less than fourfold of the maternal titer at delivery (e.g., maternal titer = 1:8, neonatal titer ≤1:16)”
Citations
Cites
Items 201–400 of 1,461
Moodley, P., Wilkinson, D., Connolly, C., Moodley, J., & Sturm, A. W. (2002) · Clinical Infectious Diseases · doi:10.1086/338399 · Cited by 284
Bradshaw, C. S., Tabrizi, S. N., Read, T. R. H., Garland, S. M., Hopkins, C. A., Moss, L. M., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/499434 · Cited by 284
Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.
Robb, M. L., Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508952 · Cited by 283
Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998–2008.
Thompson, N. D., Perz, J. F., Moorman, A. C., & Holmberg, S. D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00007 · Cited by 283
Sobel, J. D., Ferris, D., Schwebke, J., Nyirjesy, P., Wiesenfeld, H. C., Peipert, J., Soper, D., Ohmit, S. E., & Hillier, S. L. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.11.041 · Cited by 281
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.
Feldblum, P. J., Adeiga, A., Bakare, R., Wevill, S., Lendvay, A., Obadaki, F., Olayemi, M. O., Wang, L., Nanda, K., & Rountree, W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001474 · Cited by 280
(2014) · PubMed · Cited by 277
Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic.
Urbanus, A. T., van de Laar, T. J., Stolte, I. G., Schinkel, J., Heijman, T., Coutinho, R. A., & Prins, M. (2009) · AIDS · doi:10.1097/qad.0b013e32832e5631 · Cited by 276
Macy, E., & Ngor, E. W. (2013) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.02.002 · Cited by 275
Mucopurulent Cervicitis and Mycoplasma genitalium
Manhart, L. E., Critchlow, C. W., Holmes, K. K., Dutro, S. M., Eschenbach, D. A., Stevens, C. E., & Totten, P. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/367992 · Cited by 275
McDonald, H. M., O'Loughlin, J. A., Vigneswaran, R., Jolley, P. T., Harvey, J. A., Bof, A., & McDonald, P. J. (1997) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb11009.x · Cited by 272
Mass drug administration for scabies control in a population with endemic disease.
Romani, L., Whitfeld, M. J., Koroivueta, J., Kama, M., Wand, H., Tikoduadua, L., Tuicakau, M., Koroi, A., Andrews, R., Kaldor, J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500987 · Cited by 268
Characterization of vaginal flora and bacterial vaginosis in women who have sex with women.
Marrazzo, J. M., Koutsky, L. A., Eschenbach, D. A., Agnew, K., Stine, K., & Hillier, S. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/339884 · Cited by 267
Chou, R., Evans, C., Hoverman, A., Sun, C., Dana, T., Bougatsos, C., Grusing, S., & Korthuis, P. T. (2019) · JAMA · doi:10.1001/jama.2019.2591 · Cited by 266
Nye, M. B., Schwebke, J. R., & Body, B. A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.10.005 · Cited by 266
Cleland, K., Zhu, H., Goldstuck, N., Cheng, L., & Trussell, J. (2012) · Human Reproduction · doi:10.1093/humrep/des140 · Cited by 265
Nelson, N. P., Weng, M. K., Hofmeister, M. G., Moore, K. L., Doshani, M., Kamili, S., Koneru, A., Haber, P., Hagan, L., Romero, J. R., et al. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6905a1 · Cited by 264
Serologic Response to Treatment of Infectious Syphilis
Romanowski, B., Sutherland, R., Fick, G. H., Mooney, D., & Love, E. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1005 · Cited by 264
Validity of the Vaginal Gram Stain for the Diagnosis of Bacterial Vaginosis
SCHWEBKE, J. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(96)00233-5 · Cited by 264
Terrault, N. A., Dodge, J. L., Murphy, E. L., Tavis, J. E., Kiss, A., Levin, T. R., Gish, R. G., Busch, M. P., Reingold, A. L., & Alter, M. J. (2013) · Hepatology · doi:10.1002/hep.26164 · Cited by 263
Beymer, M. R., Weiss, R. E., Bolan, R. K., Rudy, E. T., Bourque, L. B., Rodriguez, J. P., & Morisky, D. E. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051494 · Cited by 262
Penicillin Allergy and Desensitization in Serious Infections during Pregnancy
Wendel, G. D., Stark, B. J., Jamison, R. B., Molina, R. D., & Sullivan, T. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121905 · Cited by 262
(2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.10.014 · Cited by 259
Kaul, R., Kimani, J., Nagelkerke, N. J., Fonck, K., Ngugi, E. N., Keli, F., MacDonald, K. S., Maclean, I. W., Bwayo, J. J., Temmerman, M., et al. (2004) · JAMA · doi:10.1001/jama.291.21.2555 · Cited by 257
Chlamydia trachomatis Persistence In Vitro: An Overview
Wyrick, P. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652394 · Cited by 257
Schachter, J., Chernesky, M. A., Willis, D. E., Fine, P. M., Martin, D. H., Fuller, D., Jordan, J. A., Janda, W., & Hook, E. W. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000190092.59482.96 · Cited by 253
(2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.06.012 · Cited by 253
Baumann, L., Cina, M., Egli-Gany, D., Goutaki, M., Halbeisen, F. S., Lohrer, G.-R., Ali, H., Scott, P., & Low, N. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053384 · Cited by 253
Trichomonas vaginalis as a Cause of Perinatal Morbidity: A Systematic Review and Meta-Analysis
Silver, B. J., Guy, R. J., Kaldor, J. M., Jamil, M. S., & Rumbold, A. R. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000134 · Cited by 252
SCHILLINGER, J. A., KISSINGER, P., CALVET, H., WHITTINGTON, W. L. H., RANSOM, R. L., STERNBERG, M. R., BERMAN, S. M., KENT, C. K., MARTIN, D. H., OH, M. K., et al. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200301000-00011 · Cited by 251
Self-citationSexually transmitted infections and risk behaviours in women who have sex with women.
Fethers, K. (2000) · Sexually Transmitted Infections · doi:10.1136/sti.76.5.345 · Cited by 251
McClelland, R. S., Lingappa, J. R., Srinivasan, S., Kinuthia, J., John-Stewart, G. C., Jaoko, W., Richardson, B. A., Yuhas, K., Fiedler, T. L., Mandaliya, K. N., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30058-6 · Cited by 251
Kirkcaldy, R. D., Harvey, A., Papp, J. R., del Rio, C., Soge, O. O., Holmes, K. K., Hook, E. W., Kubin, G., Riedel, S., Zenilman, J., et al. (2016) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6507a1 · Cited by 249
Self-citationIs sexual contact a major mode of hepatitis C virus transmission?
Tohme, R. A., & Holmberg, S. D. (2010) · Hepatology · doi:10.1002/hep.23808 · Cited by 248
Baker, K. S., Dallman, T. J., Ashton, P. M., Day, M., Hughes, G., Crook, P. D., Gilbart, V. L., Zittermann, S., Allen, V. G., Howden, B. P., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00002-x · Cited by 248
Clinical Manifestations of Vaginal Trichomoniasis
Wølner-Hanssen, P. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420040109029 · Cited by 246
McQuillan, G. M., Kruszon‐Moran, D., Flagg, E. W., et al. (2018) · PubMed · Cited by 241
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.
Wandeler, G., Gsponer, T., Bregenzer, A., Günthard, H. F., Clerc, O., Calmy, A., Stöckle, M., Bernasconi, E., Furrer, H., & Rauch, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis694 · Cited by 241
Role of saliva, urine and feces in the transmission of type B hepatitis.
Villarejos, V. M., Visoná, K. A., Alvaro, G. D., & Antonio, R. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197412262912602 · Cited by 240
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.6.947 · Cited by 239
DiNenno, E. A., Prejean, J., Irwin, K., Delaney, K. P., Bowles, K., Martin, T., Tailor, A., Dumitru, G., Mullins, M. M., Hutchinson, A. B., et al. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6631a3 · Cited by 238
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Nalugoda, F., Watya, S., Moulton, L., Chen, M. Z., Sewankambo, N. K., Kiwanuka, N., et al. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.07.069 · Cited by 237
Smith, D. K., Herbst, J. H., Zhang, X., & Rose, C. E. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000461 · Cited by 236
Sena, A. C., Miller, W. C., Hobbs, M. M., Schwebke, J. R., Leone, P. A., Swygard, H., Atashili, J., & Cohen, M. S. (2007) · Clinical Infectious Diseases · doi:10.1086/511144 · Cited by 236
Ceftriaxone-Resistant Neisseria gonorrhoeae , Japan
Ohnishi, M., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Watanabe, H., & Kitawaki, J. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.100397 · Cited by 236
Mycoplasma genitalium: prevalence, clinical significance, and transmission
Anagrius, C. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.012062 · Cited by 235
Schwebke, J. R., Rompalo, A., Taylor, S., Sena, A. C., Martin, D. H., Lopez, L. M., Lensing, S., & Lee, J. Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq074 · Cited by 235
Duration of viremia in hepatitis A virus infection.
Bower, W. A., Nainan, O. V., Han, X., & Margolis, H. S. (2000) · The Journal of Infectious Diseases · doi:10.1086/315701 · Cited by 232
Hegazi, A., Lee, M., Whittaker, W., Green, S., Simms, R., Cutts, R., Nagington, M., Nathan, B., & Pakianathan, M. (2017) · International Journal of STD & AIDS · doi:10.1177/0956462416651229 · Cited by 231
Pasternak, B. (2010) · JAMA · doi:10.1001/jama.2010.1206 · Cited by 230
Buchbinder, S. P., Vittinghoff, E., Heagerty, P. J., Celum, C. L., Seage, G. R., Judson, F. N., McKirnan, D., Mayer, K. H., & Koblin, B. A. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000134740.41585.f4 · Cited by 230
Horner, P., Donders, G., Cusini, M., Gomberg, M., Jensen, J. S., & Unemo, M. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15146 · Cited by 229
Weatherburn, P., Hickson, F., Reid, D., Torres-Rueda, S., & Bourne, A. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052695 · Cited by 229
Subclinical Pelvic Inflammatory Disease and Infertility
Wiesenfeld, H. C., Hillier, S. L., Meyn, L. A., Amortegui, A. J., & Sweet, R. L. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31825a6bc9 · Cited by 228
Peitzmeier, S. M., Reisner, S. L., Harigopal, P., & Potter, J. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2753-1 · Cited by 226
Prevalence of Trichomonas vaginalis Isolates with Resistance to Metronidazole and Tinidazole
Schwebke, J. R., & Barrientes, F. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00814-06 · Cited by 225
Anal Cancer Risk Among People With HIV Infection in the United States
Colón-López, V., Shiels, M. S., Machin, M., Ortiz, A. P., Strickler, H., Castle, P. E., Pfeiffer, R. M., & Engels, E. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9291 · Cited by 224
Jenness, S. M., Weiss, K. M., Goodreau, S. M., Gift, T., Chesson, H., Hoover, K. W., Smith, D. K., Liu, A. Y., Sullivan, P. S., & Rosenberg, E. S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix439 · Cited by 224
HIV epidemics among transgender women.
Poteat, T., Reisner, S. L., & Radix, A. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000030 · Cited by 224
Clinical experience with an inactivated hepatitis A vaccine.
Clemens, R., Safary, A., Hepburn, A., Roche, C., Stanbury, W. J., & Andre, F. E. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s44 · Cited by 223
The public health control of scabies: priorities for research and action.
Engelman, D., Cantey, P. T., Marks, M., Solomon, A. W., Chang, A. Y., Chosidow, O., Enbiale, W., Engels, D., Hay, R. J., Hendrickx, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31136-5 · Cited by 223
The evaluation of children in the primary care setting when sexual abuse is suspected.
Jenny, C., Crawford-Jakubiak, J. E., COMMITTEE ON CHILD ABUSE AND NEGLECT, Jenny, C., Crawford-Jakubiak, J. E., Christian, C. W., Crawford-Jakubiak, J. E., Flaherty, E. G., Leventhal, J. M., Lukefahr, J. L., et al. (2013) · PEDIATRICS · doi:10.1542/peds.2013-1741 · Cited by 222
Kirkcaldy, R. D., Augostini, P., Asbel, L. E., Bernstein, K. T., Kerani, R. P., Mettenbrink, C. J., Pathela, P., Schwebke, J. R., Secor, W. E., Workowski, K. A., et al. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1806.111590 · Cited by 219
Self-citationScreening for HIV Infection: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Doubeni, C. A., Epling, J. W., et al. (2019) · JAMA · doi:10.1001/jama.2019.6587 · Cited by 218
Mabey, D. (2002) · Sexually Transmitted Infections · doi:10.1136/sti.78.2.90 · Cited by 217
Read, T. R. H., Fairley, C. K., Murray, G. L., Jensen, J. S., Danielewski, J., Worthington, K., Doyle, M., Mokany, E., Tan, L., Chow, E. P. F., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy477 · Cited by 216
Is metronidazole teratogenic? A meta‐analysis
Caro‐Patón, T., Carvajal, A., Martín de Diego, I., Martín‐Arias, L. H., Alvarez Requejo, A., & Pinilla, E. R. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00660.x · Cited by 214
Manhart, L. E., Holmes, K. K., Hughes, J. P., Houston, L. S., & Totten, P. A. (2007) · American Journal of Public Health · doi:10.2105/ajph.2005.074062 · Cited by 213
Efficacy of Treatment for Syphilis in Pregnancy
ALEXANDER, J. M., SHEFFIELD, J. S., SANCHEZ, P. J., MAYFIELD, J., & WENDEL, G. D. (1999) · Obstetrics & Gynecology · doi:10.1097/00006250-199901000-00002 · Cited by 213
Pap test use is lower among female-to-male patients than non-transgender women.
Peitzmeier, S. M., Khullar, K., Reisner, S. L., & Potter, J. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.07.031 · Cited by 212
Neurosyphilis in a clinical cohort of HIV-1-infected patients.
Ghanem, K. G., Moore, R. D., Rompalo, A. M., Erbelding, E. J., Zenilman, J. M., & Gebo, K. A. (2008) · AIDS · doi:10.1097/qad.0b013e32830184df · Cited by 212
Self-citationLunny, C., Taylor, D., Hoang, L., Wong, T., Gilbert, M., Lester, R., Krajden, M., & Ogilvie, G. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132776 · Cited by 212
The Effect of Treatment of Vaginal Infections on Shedding of Human Immunodeficiency Virus Type 1
Wang, C. C., McClelland, R. S., Reilly, M., Overbaugh, J., Emery, S. R., Mandaliya, K., Chohan, B., Ndinya‐Achola, J., Bwayo, J., & Kreiss, J. K. (2001) · The Journal of Infectious Diseases · doi:10.1086/319287 · Cited by 212
Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada
Allen, V. G., Mitterni, L., Seah, C., Rebbapragada, A., Martin, I. E., Lee, C., Siebert, H., Towns, L., Melano, R. G., & Low, D. E. (2013) · JAMA · doi:10.1001/jama.2012.176575 · Cited by 212
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.22980 · Cited by 212
Rauch, A., Martin, M., Weber, R., Hirschel, B., Tarr, P. E., Bucher, H. C., Vernazza, P., Bernasconi, E., Zinkernagel, A. S., Evison, J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/431486 · Cited by 210
Gray, R., Kigozi, G., Kong, X., Ssempiija, V., Makumbi, F., Wattya, S., Serwadda, D., Nalugoda, F., Sewenkambo, N. K., & Wawer, M. J. (2012) · AIDS · doi:10.1097/qad.0b013e3283504a3f · Cited by 209
Butler, T. (2017) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0434 · Cited by 209
Reitano, M., Tyring, S., Lang, W., Thoming, C., Worm, A. ‐., Borelli, S., Chambers, L. O., Robinson, J. M., Corey, L., & the International Valaciclovir HSV Study Group (1998) · The Journal of Infectious Diseases · doi:10.1086/515385 · Cited by 209
Schillie, S., Harris, A., Link-Gelles, R., Romero, J., Ward, J., & Nelson, N. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6715a5 · Cited by 208
Horizontal transmission of hepatitis B virus.
Gray Davis, L., Weber, D., & Lemon, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92876-6 · Cited by 208
Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine
Sobel, J. D., Chaim, W., Nagappan, V., & Leaman, D. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00726-9 · Cited by 207
Patton, M. E., Kidd, S., Llata, E., Stenger, M., Braxton, J., Asbel, L., Bernstein, K., Gratzer, B., Jespersen, M., Kerani, R., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu184 · Cited by 206
Bolan, R. K., Beymer, M. R., Weiss, R. E., Flynn, R. P., Leibowitz, A. A., & Klausner, J. D. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000216 · Cited by 206
Chesson, H. W., Ekwueme, D. U., Saraiya, M., Watson, M., Lowy, D. R., & Markowitz, L. E. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.056 · Cited by 205
Serological investigation of Mycoplasma genitalium in infertile women
Clausen, H. F., Fedder, J., Drasbek, M., Nielsen, P. K., Toft, B., Ingerslev, H. J., Birkelund, S., & Christiansen, G. (2001) · Human Reproduction · doi:10.1093/humrep/16.9.1866 · Cited by 205
Huppert, J. S., Mortensen, J. E., Reed, J. L., Kahn, J. A., Rich, K. D., Miller, W. C., & Hobbs, M. M. (2007) · Clinical Infectious Diseases · doi:10.1086/518851 · Cited by 204
Hawkes, S., Matin, N., Broutet, N., & Low, N. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70104-9 · Cited by 204
(1995) · PubMed · Cited by 203
Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine
André, F. E. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90525-1 · Cited by 203
Cross-reactivity in β-Lactam Allergy
Zagursky, R. J., & Pichichero, M. E. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.08.027 · Cited by 202
Drugs of Choice for the Treatment of Uncomplicated Gonococcal Infections
Moran, J. S., & Levine, W. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_1.s47 · Cited by 202
McMahon, B. J., Bulkow, L. R., Singleton, R. J., Williams, J., Snowball, M., Homan, C., & Parkinson, A. J. (2011) · Hepatology · doi:10.1002/hep.24442 · Cited by 201
Hogewoning, C. J. A., Bleeker, M. C. G., van den Brule, A. J. C., Voorhorst, F. J., Snijders, P. J. F., Berkhof, J., Westenend, P. J., & Meijer, C. J. L. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11474 · Cited by 200
Glick, S. N., Morris, M., Foxman, B., Aral, S. O., Manhart, L. E., Holmes, K. K., & Golden, M. R. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318247925e · Cited by 199
Trelle, S., Shang, A., Nartey, L., Cassell, J. A., & Low, N. (2007) · BMJ · doi:10.1136/bmj.39079.460741.7c · Cited by 199
Zou, S., Stramer, S. L., & Dodd, R. Y. (2012) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2011.07.007 · Cited by 198
Molecular Diagnosis of Bacterial Vaginosis: an Update
Coleman, J. S., & Gaydos, C. A. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00342-18 · Cited by 198
Orland, J. R., Wright, T. L., & Cooper, S. (2001) · Hepatology · doi:10.1053/jhep.2001.22112 · Cited by 196
Polis, C. B., Curtis, K. M., Hannaford, P. C., Phillips, S. J., Chipato, T., Kiarie, J. N., Westreich, D. J., & Steyn, P. S. (2016) · AIDS · doi:10.1097/qad.0000000000001228 · Cited by 196
Stone, K. M., Reiff‐Eldridge, R., White, A. D., Cordero, J. F., Brown, Z., Alexander, E. R., & Andrews, E. B. (2004) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20013 · Cited by 196
Fluconazole-Resistant Candida albicans Vulvovaginitis
Marchaim, D., Lemanek, L., Bheemreddy, S., Kaye, K. S., & Sobel, J. D. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31827307b2 · Cited by 195
Bissessor, M., Tabrizi, S. N., Twin, J., Abdo, H., Fairley, C. K., Chen, M. Y., Vodstrcil, L. A., Jensen, J. S., Hocking, J. S., Garland, S. M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1162 · Cited by 195
Marra, C. M., Boutin, P., McArthur, J. C., Hurwitz, S., Simpson, G., Haslett, J. P. A., van der Horst, C., Nevin, T., Hook, E. W., & AIDS Clinical Trials Group (ACTG) 145 Team (2000) · Clinical Infectious Diseases · doi:10.1086/313725 · Cited by 194
Cottrell, E. B., Chou, R., Wasson, N., Rahman, B., & Guise, J.-M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-2-201301150-00575 · Cited by 194
Mastromarino, P., Macchia, S., Meggiorini, L., Trinchieri, V., Mosca, L., Perluigi, M., & Midulla, C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02112.x · Cited by 194
Myer, L., Kuhn, L., Stein, Z. A., Wright, T. C., & Denny, L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70298-x · Cited by 193
Lamont, R. F., Nhan-Chang, C.-L., Sobel, J. D., Workowski, K., Conde-Agudelo, A., & Romero, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.03.047 · Cited by 190
Self-citationProbiotics for the treatment of bacterial vaginosis
Senok, A. C., Verstraelen, H., Temmerman, M., & Botta, G. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006289.pub2 · Cited by 189
Cahill, S. R., Baker, K., Deutsch, M. B., Keatley, J., & Makadon, H. J. (2016) · LGBT Health · doi:10.1089/lgbt.2015.0136 · Cited by 188
The safety of intrauterine devices among young women: a systematic review
Jatlaoui, T. C., Riley, H. E. M., & Curtis, K. M. (2017) · Contraception · doi:10.1016/j.contraception.2016.10.006 · Cited by 187
Warner, L., Stone, K. M., Macaluso, M., Buehler, J. W., & Austin, H. D. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000187908.42622.fd · Cited by 187
Conley, L. J., Ellerbrock, T. V., Bush, T. J., Chiasson, M. A., Sawo, D., & Wright, T. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07368-3 · Cited by 186
(2008) · PubMed · Cited by 186
Blumenthal, K. G., Shenoy, E. S., Varughese, C. A., Hurwitz, S., Hooper, D. C., & Banerji, A. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.05.011 · Cited by 185
Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis
Krieger, J. N., Riley, D. E., Roberts, M. C., & Berger, R. E. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.3120-3128.1996 · Cited by 185
Unemo, M., Golparian, D., Syversen, G., Vestrheim, D. F., & Moi, H. (2010) · Eurosurveillance · doi:10.2807/ese.15.47.19721-en · Cited by 185
Pond, M. J., Nori, A. V., Witney, A. A., Lopeman, R. C., Butcher, P. D., & Sadiq, S. T. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit752 · Cited by 184
Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis.
Pichichero, M. E., & Casey, J. R. (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2006.10.007 · Cited by 184
WHITTINGTON, W. L. H., KENT, C., KISSINGER, P., OH, M. K., FORTENBERRY, J. D., HILLIS, S. E., LITCHFIELD, B., BOLAN, G. A., ST. LOUIS, M. E., FARLEY, T. A., et al. (2001) · Sex Transm Dis · doi:10.1097/00007435-200102000-00011 · Cited by 182
Self-citationReyes, M. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.76 · Cited by 181
Richel, O., de Vries, H. J., van Noesel, C. J., Dijkgraaf, M. G., & Prins, J. M. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70067-6 · Cited by 181
Peterman, T. A., Tian, L. H., Metcalf, C. A., Satterwhite, C. L., Malotte, C. K., DeAugustine, N., Paul, S. M., Cross, H., Rietmeijer, C. A., Douglas, J. M., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00005 · Cited by 181
Ghanem, K. G., Erbelding, E. J., Wiener, Z. S., & Rompalo, A. M. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2006.021402 · Cited by 177
Watts, D. H., Brown, Z. A., Money, D., Selke, S., Huang, M. L., Sacks, S. L., & Corey, L. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.185 · Cited by 177
Identification of novel microbes associated with pelvic inflammatory disease and infertility
Haggerty, C. L., Totten, P. A., Tang, G., Astete, S. G., Ferris, M. J., Norori, J., Bass, D. C., Martin, D. H., Taylor, B. D., & Ness, R. B. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052285 · Cited by 175
Ginocchio, C. C., Chapin, K., Smith, J. S., Aslanzadeh, J., Snook, J., Hill, C. S., & Gaydos, C. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00748-12 · Cited by 175
Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.
Kissinger, P., Mohammed, H., Richardson-Alston, G., Leichliter, J. S., Taylor, S. N., Martin, D. H., & Farley, T. A. (2005) · Clinical Infectious Diseases · doi:10.1086/432476 · Cited by 174
Edgren, G., & Sparén, P. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70043-8 · Cited by 174
Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
Chisholm, S. A., Mouton, J. W., Lewis, D. A., Nichols, T., Ison, C. A., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq289 · Cited by 174
Lymphogranuloma Venereum in the United Kingdom
Ward, H., Martin, I., Macdonald, N., Alexander, S., Simms, I., Fenton, K., French, P., Dean, G., & Ison, C. (2007) · Clinical Infectious Diseases · doi:10.1086/509922 · Cited by 174
Ong, J. J., Baggaley, R. C., Wi, T. E., Tucker, J. D., Fu, H., Smith, M. K., Rafael, S., Anglade, V., Falconer, J., Ofori-Asenso, R., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17134 · Cited by 173
Ingiliz, P., Martin, T. C., Rodger, A., Stellbrink, H.-J., Mauss, S., Boesecke, C., Mandorfer, M., Bottero, J., Baumgarten, A., Bhagani, S., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.004 · Cited by 173
Walter, B., Heukelbach, J., Fengler, G., Worth, C., Hengge, U., & Feldmeier, H. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.51 · Cited by 173
Grohskopf, L. A., Chillag, K. L., Gvetadze, R., Liu, A. Y., Thompson, M., Mayer, K. H., Collins, B. M., Pathak, S. R., O'Hara, B., Ackers, M. L., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31828ece33 · Cited by 172
Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010
Ison, C. A., Hussey, J., Sankar, K. N., Evans, J., & Alexander, S. (2011) · Eurosurveillance · doi:10.2807/ese.16.14.19833-en · Cited by 172
Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis
Cohen, C. R. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2005.015701 · Cited by 172
Genital Herpes Simplex Virus Infections: Current Concepts in Diagnosis, Therapy, and Prevention
LAWRENCE, C., & HOLMES, K. K. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-973 · Cited by 172
Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility—a prospective study
Svenstrup, H. F., Fedder, J., Kristoffersen, S. E., Trolle, B., Birkelund, S., & Christiansen, G. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.056 · Cited by 171
Zozaya, M., Ferris, M. J., Siren, J. D., Lillis, R., Myers, L., Nsuami, M. J., Eren, A. M., Brown, J., Taylor, C. M., & Martin, D. H. (2016) · Microbiome · doi:10.1186/s40168-016-0161-6 · Cited by 171
Natural History of Genital Herpes Simplex Virus Type 1 Infection
ENGELBERG, R., CARRELL, D., KRANTZ, E., COREY, L., & WALD, A. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200302000-00015 · Cited by 170
Natural history, clinical manifestations, and pathogenesis of hepatitis A.
Shin, E.-C., & Jeong, S.-H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031708 · Cited by 170
Bachmann, L. H., Johnson, R. E., Cheng, H., Markowitz, L., Papp, J. R., Palella, F. J., & Hook, E. W. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02398-09 · Cited by 170
Self-citationTreatment of cervicitis is associated with decreased cervical shedding of HIV-1
McClelland, R. S., Wang, C. C., Mandaliya, K., Overbaugh, J., Reiner, M. T., Panteleeff, D. D., Lavreys, L., Ndinya-Achola, J., Bwayo, J. J., & Kreiss, J. K. (2001) · AIDS · doi:10.1097/00002030-200101050-00015 · Cited by 170
Gilbart, V. L., Simms, I., Jenkins, C., Furegato, M., Gobin, M., Oliver, I., Hart, G., Gill, O. N., & Hughes, G. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052014 · Cited by 170
Bacterial vaginosis and risk of pelvic inflammatory disease.
Ness, R. B., Hillier, S. L., Kip, K. E., Soper, D. E., Stamm, C. A., McGregor, J. A., Bass, D. C., Sweet, R. L., Rice, P., & Richter, H. E. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000139512.37582.17 · Cited by 169
Tyring, S. K., Baker, D., & Snowden, W. (2002) · The Journal of Infectious Diseases · doi:10.1086/342966 · Cited by 169
Hammerschlag, M. R., Cummings, C., Roblin, P. M., Williams, T. H., & Delke, I. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903233201204 · Cited by 168
National Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae
Schwarcz, S. K. (1990) · JAMA · doi:10.1001/jama.264.11.1413 · Cited by 168
Modern diagnosis of Trichomonas vaginalis infection
Hobbs, M. M., & Seña, A. C. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051057 · Cited by 168
Kim, J. J., Burger, E. A., Regan, C., & Sy, S. (2018) · JAMA · doi:10.1001/jama.2017.19872 · Cited by 168
Defining Cerebrospinal Fluid White Blood Cell Count Reference Values in Neonates and Young Infants
Kestenbaum, L. A., Ebberson, J., Zorc, J. J., Hodinka, R. L., & Shah, S. S. (2010) · Pediatrics · doi:10.1542/peds.2009-1181 · Cited by 168
Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana.
Martinson, F. E. A., Weigle, K. A., Royce, R. A., Weber, D. J., Suchindran, C. M., & Lemon, S. M. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009474 · Cited by 168
Lambers, F. A. E., Prins, M., Thomas, X., Molenkamp, R., Kwa, D., Brinkman, K., van der Meer, J. T. M., & Schinkel, J. (2011) · AIDS · doi:10.1097/qad.0b013e32834bac44 · Cited by 167
Tinidazole Therapy for Metronidazole‐Resistant Vaginal Trichomoniasis
Sobel, J. D., Nyirjesy, P., & Brown, W. (2001) · Clinical Infectious Diseases · doi:10.1086/323034 · Cited by 167
Comprehensive clinical care for men who have sex with men: an integrated approach.
Mayer, K. H., Bekker, L.-G., Stall, R., Grulich, A. E., Colfax, G., & Lama, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60835-6 · Cited by 167
Geisler, W. M., Wang, C., Morrison, S. G., Black, C. M., Bandea, C. I., & Hook, E. W. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318151497d · Cited by 166
Winer, R. L., Hughes, J. P., Feng, Q., Xi, L. F., Cherne, S., O'Reilly, S., Kiviat, N. B., & Koutsky, L. A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1108 · Cited by 166
Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020
Barrow, R. Y., Ahmed, F., BOLAN, G. A., & Workowski, K. (2020) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6805a1 · Cited by 165
Self-citationLau, A., Bradshaw, C. S., Lewis, D., Fairley, C. K., Chen, M. Y., Kong, F. Y. S., & Hocking, J. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ644 · Cited by 164
Interpretation of medical findings in suspected child sexual abuse: an update for 2018.
Adams, J. A., Farst, K. J., & Kellogg, N. D. (2018) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.12.011 · Cited by 163
Missed opportunities for prevention of congenital syphilis—United States, 2018.
Kimball, A., Torrone, E., Miele, K., Bachmann, L., Thorpe, P., Weinstock, H., & Bowen, V. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6922a1 · Cited by 163
Self-citationBradshaw, C. S., Vodstrcil, L. A., Hocking, J. S., Law, M., Pirotta, M., Garland, S. M., De Guingand, D., Morton, A. N., & Fairley, C. K. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis1030 · Cited by 162
Kirkcaldy, R. D., Weinstock, H., Moore, P. C., Philip, S., Wiesenfeld, H. C., Papp, J. R., Kerndt, P. R., Johnson, S. M., Ghanem, K. G., Hook, E. W., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu521 · Cited by 162
Self-citationRomano, A., Gaeta, F., Valluzzi, R. L., Caruso, C., Rumi, G., & Bousquet, P. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.052 · Cited by 162
Albin, S., & Agarwal, S. (2014) · Allergy and Asthma Proceedings · doi:10.2500/aap.2014.35.3791 · Cited by 162
Treatment of syphilis in pregnancy and prevention of congenital syphilis.
Wendel Jr., G. D., Sheffield, J. S., Hollier, L. M., Hill, J. B., Ramsey, P. S., & Sánchez, P. J. (2002) · Clinical Infectious Diseases · doi:10.1086/342108 · Cited by 162
Threat to Cefixime Treatment for Gonorrhea
Yokoi, S., Deguchi, T., Ozawa, T., Yasuda, M., Ito, S.-I., Kubota, Y., Tamaki, M., & Maeda, S.-I. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1308.060948 · Cited by 162
Trichomonas Vaginalis Treatment Reduces Vaginal HIV-1 Shedding
Kissinger, P., Amedee, A., Clark, R. A., Dumestre, J., Theall, K. P., Myers, L., Hagensee, M. E., Farley, T. A., & Martin, D. H. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318186decf · Cited by 161
(2008) · PubMed · Cited by 161
Fetal syphilis: clinical and laboratory characteristics
Hollier, L. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01367-9 · Cited by 160
Solomon, M. M., Mayer, K. H., Glidden, D. V., Liu, A. Y., McMahan, V. M., Guanira, J. V., Chariyalertsak, S., Fernandez, T., Grant, R. M., Bekker, L.-G., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu450 · Cited by 159
Marra, C. M., Maxwell, C. L., Tantalo, L. C., Sahi, S. K., & Lukehart, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/591534 · Cited by 159
Kong, F. Y. S., Tabrizi, S. N., Law, M., Vodstrcil, L. A., Chen, M., Fairley, C. K., Guy, R., Bradshaw, C., & Hocking, J. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu220 · Cited by 159
Brown, Z. A., Wald, A., Morrow, R. A., Selke, S., Zeh, J., & Corey, L. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000070126.90718.7b · Cited by 159
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
Murray, G. L., Bradshaw, C. S., Bissessor, M., Danielewski, J., Garland, S. M., Jensen, J. S., Fairley, C. K., & Tabrizi, S. N. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2305.161745 · Cited by 159
Is Mycoplasma genitalium in Women the “New Chlamydia?” A Community‐Based Prospective Cohort Study
Oakeshott, P., Aghaizu, A., Hay, P., Reid, F., Kerry, S., Atherton, H., Simms, I., Taylor‐Robinson, D., Dohn, B., & Jensen, J. S. (2010) · Clinical Infectious Diseases · doi:10.1086/656739 · Cited by 157
Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing.
Iammatteo, M., Alvarez Arango, S., Ferastraoaru, D., Akbar, N., Lee, A. Y., Cohen, H. W., & Jerschow, E. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.05.008 · Cited by 157
Fung, M., Scott, K. C., Kent, C. K., & Klausner, J. D. (2006) · Sexually Transmitted Infections · doi:10.1136/sti.2006.024059 · Cited by 157
Preventing Adverse Sequelae of Bacterial Vaginosis: A Public Health Program and Research Agenda
KOUMANS, E. H., & Kendrick, J. S. (2001) · Sexually Transmitted Diseases · doi:10.1097/00007435-200105000-00011 · Cited by 156
Van Der Pol, B., Williams, J. A., Orr, D. P., Batteiger, B. E., & Fortenberry, J. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/498217 · Cited by 156
Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting.
Montaño, M. A., Dombrowski, J. C., Dasgupta, S., Golden, M. R., Duerr, A., Manhart, L. E., Barbee, L. A., & Khosropour, C. M. (2019) · AIDS and Behavior · doi:10.1007/s10461-018-2252-9 · Cited by 155
Potter, J. E., Peitzmeier, S. M., Bernstein, I. M., Reisner, S. L., Alizaga, N. M., Agénor, M., & Pardee, D. J. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3462-8 · Cited by 155
Blondeau, J. M., Hansen, G., Metzler, K., et al. (2004) · Journal of Chemotherapy · doi:10.1080/1120009x.2004.11782371 · Cited by 155
Goodenow, C., Szalacha, L. A., Robin, L. E., & Westheimer, K. (2008) · American Journal of Public Health · doi:10.2105/ajph.2005.080531 · Cited by 155
Molecular Testing for Trichomonas vaginalis in Women: Results from a Prospective U.S. Clinical Trial
Schwebke, J. R., Hobbs, M. M., Taylor, S. N., Sena, A. C., Catania, M. G., Weinbaum, B. S., Johnson, A. D., Getman, D. K., & Gaydos, C. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01291-11 · Cited by 155
Unemo, M., Golparian, D., & Hestner, A. (2011) · Eurosurveillance · doi:10.2807/ese.16.06.19792-en · Cited by 155
Genital human papillomavirus infection in women who have sex with women.
Marrazzo, J. M., Koutsky, L. A., Stine, K. L., Kuypers, J. M., Grubert, T. A., Galloway, D. A., Kiviat, N. B., & Handsfield, H. H. (1998) · The Journal of Infectious Diseases · doi:10.1086/314494 · Cited by 154
Abara, W. E., Qaseem, A., Schillie, S. F., McMahon, B. J., Harris, A. M., Abraham, G. M., Centor, R., DeLong, D. M., Gantzer, H. E., Horwitch, C. A., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1106 · Cited by 154
Detection of Trichomonosis in Vaginal and Urine Specimens from Women by Culture and PCR
Lawing, L. F., Hedges, S. R., & Schwebke, J. R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3585-3588.2000 · Cited by 154
Macy, E., & Contreras, R. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.062 · Cited by 153
The clinical diagnosis of genital ulcer disease in men.
DiCarlo, R. P., & Martin, D. H. (1997) · Clinical Infectious Diseases · doi:10.1086/514548 · Cited by 152
A proactive approach to penicillin allergy testing in hospitalized patients.
Chen, J. R., Tarver, S. A., Alvarez, K. S., Tran, T., & Khan, D. A. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.09.045 · Cited by 152
Subtil, D., Brabant, G., Tilloy, E., Devos, P., Canis, F., Fruchart, A., Bissinger, M.-C., Dugimont, J.-C., Nolf, C., Hacot, C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31617-9 · Cited by 152
Reisner, S. L., Perkovich, B., & Mimiaga, M. J. (2010) · AIDS Patient Care and STDs · doi:10.1089/apc.2010.0059 · Cited by 152
BVBlue Test for Diagnosis of Bacterial Vaginosis
Myziuk, L., Romanowski, B., & Johnson, S. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.5.1925-1928.2003 · Cited by 151
The Relationship between Condom Use and Herpes Simplex Virus Acquisition
Wald, A., Langenberg, A. G. M., Krantz, E., Douglas, J. M., Handsfield, H. H., DiCarlo, R. P., Adimora, A. A., Izu, A. E., Morrow, R. A., & Corey, L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00007 · Cited by 151
Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins.
Novalbos, A., Sastre, J., Cuesta, J., De Las Heras, M., Lluch‐Bernal, M., Bombín, C., & Quirce, S. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.00992.x · Cited by 151
Gaydos, C. A., Maldeis, N. E., Hardick, A., Hardick, J. P., & Quinn, T. C. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181b01948 · Cited by 150
Research works printed but not linked: 13
- Golden MR, Kerani RP, Stenger M, Effect of expedited partner therapy (EPT) on chlamydial prevalence: the Washington State Community-Level Trial. Presented at the STD Prevention Conference, Minneapolis, MN; March 12–15, 2012.
- Lin JS, Eder M, Bean S. Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 167. AHRQ Publication No. 18-05238-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018. 30234936
- Benton S, Smith J, Wang F, Heitgerd J, Belcher L, Patel H. HIV testing, diagnosis, and linkage to care among persons tested in select CDC-funded health care and non-health care settings, 2012–2017. Presented at the National HIV Prevention Conference, Atlanta, GA: March 18–21, 2019.
- Briggs GC. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017.
- Blanco JL, Fuertes I, Bosch J, Effective treatment of lymphogranuloma venereum (LGV) with 1g azithormycin administered weekly for 3 weeks in HIV-infected population. Presented at the Conference on Retroviruses and Opportunist Infections, Seattle, WA; February 23–26, 2015.
- Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 · DOI · Paper page
- Ahmed KA, Fox SJ, Frigas E, Park MA. Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy. Int Arch Allergy Immunol 2012; 158: 405– 10. 10.1159/000333553 22487723 · DOI · Paper page
- Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204: 1297– 304. 10.1093/infdis/jir524 21930610 · DOI · Paper page
- Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 2014; 59: 834– 41. 10.1093/cid/ciu446 24928292 · DOI · Paper page
- Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33: 1341– 6. 10.1086/323034 11565074 · DOI · Paper page
- Perkins RB, Guido RS, Castle PE,; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24: 102– 31. 10.1097/LGT.0000000000000525 32243307 PMC7147428 · DOI · Paper page
- Al Jaff DAA, Amin MHM. Comparison of the effectiveness of sulphur ointment, permethrin and oral ivermectin in treatment of scabies. Res J Pharm Biol Chem Sci 2018; 9: 670– 6.
- Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: a review of comparative clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2019. https://www.ncbi.nlm.nih.gov/books/NBK545083/ 31424718
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2211934 · Cited by 468
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 382
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Diagnosis and Treatment of Sexually Transmitted Infections: A Review
Tuddenham, S., Hamill, M. M., & Ghanem, K. G. (2022) · JAMA · doi:10.1001/jama.2021.23487 · Cited by 302
Metadata
- Authors
- Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A.
- Affiliations
- Emory University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Brown University (US)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Workowski, Kimberly A.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2021-07-23
- Volume
- 70
- Issue
- 4
- Pages
- 1-187
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8344968
- OpenAlex
- W3185444663
- Semantic Scholar
- eb300ecb7d38078ce65557d8188da1edbd3174fc
- Cited by
- 3,018
- References
- 1,505
- Citations by year
- 2026: 740 · 2025: 655 · 2024: 606 · 2023: 558 · 2022: 385 · 2021: 64
- FWCI
- 256.76
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R25MH083620)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- sexually transmitted infections, STI treatment, gonorrhea, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, bacterial vaginosis, Mycoplasma genitalium, HPV vaccine, HCV screening, HIV prevention
- MeSH terms
- Centers for Disease Control and Prevention, U.S., Humans, Sexually Transmitted Diseases, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
